SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001558370-17-001941
Filing Date
2017-03-20
Accepted
2017-03-20 08:00:40
Documents
5
Effectiveness Date
2017-03-20

Document Format Files

Seq Description Document Type Size
1 S-8 syrs_currentfolios-8.htm S-8 165956
2 EX-5.1 syrs_s8exh5.htm EX-5.1 17308
3 EX-23.2 syrs_s8exh232.htm EX-23.2 4522
4 GRAPHIC syrss8exh5001.jpg GRAPHIC 14081
5 GRAPHIC syrss8exh5002.jpg GRAPHIC 110436
  Complete submission text file 0001558370-17-001941.txt   360606
Mailing Address 620 MEMORIAL DRIVE SUITE 300 CAMBRIDGE MA 02139
Business Address 620 MEMORIAL DRIVE SUITE 300 CAMBRIDGE MA 02139 617-744-1340
Syros Pharmaceuticals, Inc. (Filer) CIK: 0001556263 (see all company filings)

IRS No.: 453772460 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-216821 | Film No.: 17700089
SIC: 2834 Pharmaceutical Preparations